| Total Revenue (Q1) | $180.2M | CFO |
| Product Revenue (Q1) | $88M | CEO, CFO |
| Royalty Revenue (Q1) | $69.6M | CFO |
| Licensing Billings (Q1) | $70.8M | CFO |
| Contract & Other Revenue (Q1) | $22.6M | CFO |
| Non-GAAP Net Income (Q1) | $69.3M | CFO |
| Operating Cash Flow (Q1) | $83M | CFO |
| Free Cash Flow (Q1) | $66.3M | CFO |
| CapEx (Q1) | $17M | CFO |
| Cash & Securities (Q1 end) | $786M | CFO |
| Inventory Change (Q1) | +$14M | CFO |
| Non-GAAP Total Op Costs (Q1) | $104.6M | CFO |
| Interest & Other Income (Q1) | $6.9M | CFO |
| Depreciation (Q1) | $8.5M | CFO |
| Revenue Guidance (Q2) | $192M–$198M | CFO |
| Product Revenue Guidance (Q2) | $95M–$101M | CFO |
| Royalty Revenue Guidance (Q2) | $72M–$78M | CFO |
| Licensing Billings Guidance (Q2) | $76M–$82M | CFO |
| Non-GAAP Op Costs Guidance (Q2) | $110M–$114M | CFO |
| CapEx Guidance (Q2) | ~$14M | CFO |
| Non-GAAP Operating Profit Guidance (Q2) | $78M–$88M | CFO |
| Non-GAAP EPS Guidance (Q2) | $0.65–$0.73 | CFO |
| Diluted Shares Guidance (Q2) | 110M | CFO |
| Non-GAAP Tax Expense Guidance (Q2) | $13.6M–$15.2M | CFO |